Autopsy report · NCT01458639

Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism

“Decision to change trial design.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 2 years 10 months before it stopped.
• 18 participants enrolled.
• Results were posted on the registry 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Cyclomedica Australia PTY Limited

Sponsor type

Industry

Conditions

Pulmonary Embolism

Interventions

Technegas V SPECT imaging; Xenon-133 Ventilation Planar imaging

Participants

18

Sites

2

Countries

United States

Trials that died the same way

• A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
  “Decision to change the study design” (73% match in meaning)
• A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
  “Decision was made by Sponsor to stop the trial.” (68% match in meaning)
• The CONNECT Program: Testing a Telephone-Based Mental Health Intervention for Older Adults
  “Change in study design was implemented and the study design no longer follows a pilot randomized controlled trial.” (67% match in meaning)
• Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
  “Company decision to discontinue trial” (67% match in meaning)
• A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
  “Not due to safety concerns, but changes in strategy which this trial no longer fulfills.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.